---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-25-000021"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2025-02-05T23:59:59+00:00"
generated_at: "2026-05-27T02:49:24.220000+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# GoodRx names Christopher McGinnis as CFO, effective Feb 4, 2025

## Summary
- McGinnis was CEO of Citizens Rx; succeeds Romin Nabiey (interim CFO), who remains CAO.
- Base salary of $500,000; eligible for annual cash bonus targeted at 100% of base salary.
- One-time signing bonus of $250,000; must remain employed through first anniversary or repay pro-rata.
- Equity awards totaling $7M: $3.5M RSU and $3.5M option; vest 25% on Feb 15, 2026 then quarterly over 4 years.
- McGinnis becomes a Tier 1 participant in the Executive Severance Plan.

## SEC filing metadata
- accession: 0001809519-25-000021
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2025-02-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951925000021/0001809519-25-000021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951925000021/gdrx-20250204.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-25-000021
- JSON: https://secwatch.observer/filing/0001809519-25-000021.json
- Plain text: https://secwatch.observer/filing/0001809519-25-000021.txt

## Key facts
- Executive change
  Christopher A. McGinnis was appointed as Chief Financial Officer and Treasurer at GoodRx Holdings, Inc..
  - Action: appointed
  - Role: Chief Financial Officer and Treasurer
  source text: On February 4, 2025, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”) appointed Christopher A. McGinnis as Chief Financial Officer and Treasurer of the Company, effective as of his commencement of employment, which occurred on February 4, 2025 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951925000021/0001809519-25-000021-index.htm
- Executive change
  Romin Nabiey changed role as Chief Accounting Officer at GoodRx Holdings, Inc..
  - Role: Chief Accounting Officer
  source text: Mr. McGinnis succeeds Romin Nabiey who, as previously disclosed, has been serving as Interim Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951925000021/0001809519-25-000021-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.